European Urology

Article	Citations
Reply to Brett Delahunt, Hemamali Samaratunga, Lars Egevad’s Letter to the Editor re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading of Chromophobe Renal Cell Carcinoma: Eviden	936
Reply to Francesco Montorsi, Nicola Fossati, Carlo A. Bravi, Giorgio Gandaglia, Nazareno Suardi, and Alberto Briganti’s Letter to the Editor re: Sophie Knipper, Luigi Ascalone, Benjamin Ziegler, et al	886
Acknowledgement to Reviewers	510
Paving the Road to the Future of Chemoradiotherapy in Muscle-invasive Bladder Cancer: 10-year Follow-up of BC2001	392
Aberrant Splice Variants: A Novel Characterization of Clear Cell Renal Cell Carcinoma	389
Quality and Quantity: Evaluating Tumor Biology Alongside Novel Imaging on Diagnosis of Metastatic Hormone-sensitive Prostate Cancer	352
Reply to Binghao Zhao, Ruidong Zhang, and Jiaming Wu’s Letter to the Editor re: Ana Cavillon, Damien Pouessel, Nadine Houédé, et al. Assessing Long-term Treatment Benefits Using Complementary Statisti	303
The Platinum Hall of Fame	272
Reply to Rui-Cheng Wu, Deng-Xiong Li, and De-Chao Feng’s Letter to the Editor re: Michael Eppler, Conner Ganjavi, Lorenzo Storino Ramacciotti, et al. Awareness and Use of ChatGPT and Large Language Mo	270
Prostate Cancer Screening at its Best: The Swedish Organized Prostate Cancer Testing Program	266
Re: Michael Eppler, Conner Ganjavi, Lorenzo Storino Ramacciotti, et al. Awareness and Use of ChatGPT and Large Language Models: A Prospective Cross-sectional Global Survey in Urology. Eur Urol. 2024;8	238
Opening up the Market to New Robotic Platforms: The Best Way To Handle New Options	224
Congress Calendar	221
Editorial Board	195
Re: Sophie Knipper, Mehrdad Mehdi Irai, Ricarda Simon, et al. Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via P	187
Behavior of SelectMDx and Prostate-specific Antigen Density in the Challenging Scenario of Prostate Imaging-Reporting and Data System Category 3 Lesions	174
Reply to Fabio Campodonico, Francesca Mattioli, and Carlo Introini’s Letter to the Editor re: Wei Shen Tan, Aaron Pendergast, Charlotte Ackerman, et al. Intravesical Chemohyperthermia Versus Passive C	169
Reply to Xiangyang Yao, Chen Duan, Bo Li, Xiaoliang Wu and Hua Xu’s Letter to the Editor Re: Hilda A. de Barros, Matthias N. van Oosterom, Maarten L. Donswijk, et al. Robot-assisted Prostate-specific	155
Editorial Board	143
Congress Calendar	135
Reply to Alessia Cimadamore, Antonio Lopez-Beltran, Marina Scarpelli, and Rodolfo Montironi’s Letter to the Editor re: Timothy D. Jones, Liang Cheng. Histologic Grading of Bladder Tumors: Using Both t	133
The Platinum Hall of Fame	130
Reply to Feng Qi, Zicheng Xu, and Qing Zou’s Letter to the Editor re: Andrea Loehr, Arif Hussain, Akash Patnaik, et al. Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-res	125
Editorial Board	115
Heterogeneity of the Treatment Effect with PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer: A Living Interactive Systematic Review and Meta-analysis	114

Infigratinib Versus Placebo for Patients with High-risk Resected Urothelial Cancer Bearing an FGFR3 Genomic Alteration: Results from the PROOF302 Phase 3 Trial	113
Re: Whole-genome Mutational Analysis for Tumor-informed Detection of Circulating Tumor DNA in Patients with Urothelial Carcinoma	112
Honing Stratification and Treatment for High-risk Prostate Cancer	111
Radiopharmaceuticals in Genitourinary Cancers: A Fast-evolving Field with a Bright Perspective	111
Oncological Benefits of Extended Pelvic Lymph Node Dissection: More Fog or Clarity to the Debate?	105
Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution	103
Editorial Board	98
Congress Calendar	96
Patient and Carer Experiences with Bladder Cancer: Results from a Global Survey in 45 Countries	93
Contents	93
Re: Angelo Territo, Luca Afferi, Mireia Musquera, et al. Robot-assisted Kidney Transplantation: The 8-year European Experience. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.12.005	92
Re: Tranexamic Acid During Radical Cystectomy: A Randomized Clinical Trial	89
T-Cell Engagers in Prostate Cancer: Promise, Challenges, and the Road Ahead	89
Contents	87
T-cell Engagers in Prostate Cancer	87
Contents	85
Reply to Marc Furrer, Niranjan J. Sathianathen, and Nathan Lawrentschuk’s Letter to the Editor re: Pietro Piazza, Luca Sarchi, Stefano Puliatti, Carlo Andrea Bravi, Sophie Knipper, Alexandre Mottrie.	83
Application of deep learning convolutional neural network in prediction of stone location, skin to stone distance and composition in renal lithiasis: A single center pilot study	81
Genitourinary Symptoms Caused by Monkeypox Virus: What Urologists Should Know	80
Re: Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen P	79
Bladder Outlet Obstruction Relief and Symptom Improvement Following Medical and Surgical Therapies for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A Systematic Review	78
Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality: 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Canc	77
Thulium Fiber Laser Versus Holmium:Yttrium Aluminum Garnet for Lithotripsy: Which Is the Winner?	77
Re: Hendrik Van Poppel, Monique J. Roobol, Christopher R. Chapple, et al. Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association	76
Ischemia Time Has Little Influence on Renal Function Following Partial Nephrectomy: Is It Time for Urology to Stop the Tick-Tock Dance?	76
Re: Syed A. Hussain, Nuria Porta, Emma Hall, et al. Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by (Chemo)radiotherapy in the BC2001 Trial.	76
Editorial Board	75
Re: Percentage Gleason Pattern 4 and PI-RADS Score Predict Upgrading in Biopsy Grade Group 2 Prostate Cancer Patients Without Cribriform Pattern	74
Re: Unplanned Conversion from Partial to Radical Nephrectomy: An Analysis of Incidence, Etiology, and Risk Factors	73
Is Office-based Management of Intermediate-risk Low-grade Non–muscle-invasive Bladder Cancer Ready For Prime Time?	73
Platinum Hall of Fame	72
Re: Farnoosh Nik-Ahd, Andrew Jarjour, Jane Figueiredo, et al. Prostate-specific Antigen Screening in Transgender Patients. Eur Urol. 2023;83:48–54	71
Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement	70
Re: Sacral Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction	69
Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion Versus Open Radical Surgery: All Is in the Eye of the Beholder	69
Putting Precision Medicine in Prostate Cancer into Practice: Are We There Yet?	69
Reply to Borivoj Golijanin, Anthony Mega, and Dragan Golijanin’s Letter to the Editor re: Ivo I. de Vos, Sebastiaan Remmers, Renée Hogenhout, Monique J. Roobol, ERSPC Rotterdam Study Group. Prostate C	68
Reply to Kunlin Yang, Xuesong Li, and Liqun Zhou’s Letter to the Editor re: Eduard Roussel, Giovanni Tasso, Riccardo Campi, et al. Surgical Management and Outcomes of Renal Tumors Arising from Horsesh	68
Re: Nivolumab plus Cabozantinib Versus Sunitinib for Advanced Renal-cell Carcinoma	67
Still Unanswered: The Role of Extended Pelvic Lymphadenectomy in Improving Oncological Outcomes in Prostate Cancer	65
Reply to Deepansh Dalela, Isaac Palma-Zamora, and Craig Rogers’ Letter to the Editor re: Fredrick Leidberg, Petter Kollberg, Marie Allerbo, et al. Preventing Parastomal Hernia After Ileal Conduit by t	65
Re: Surgical Treatment for Recurrent Bulbar Urethral Stricture: A Randomised Open-label Superiority Trial of Open Urethroplasty Versus Endoscopic Urethrotomy (the OPEN Trial)	65
Re: Pretransplant Solid Organ Malignancy and Organ Transplant Candidacy: A Consensus Expert Opinion Statement	65
Reply to Jason Koehler and Abhinav Sidana’s Letter to the Editor re: Guillaume Ploussard, Patrick Coloby, Thierry Chevallier, et al. Whole-gland or Subtotal High-intensity Focused Ultrasound Versus Ra	64
Magnetic Resonance Imaging–guided Adaptive Radiotherapy for Urological Cancers: What Urologists Should Know	63
Re: Sarah P. Psutka, Roman Gulati, Michael A.S. Jewett, et al. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-inst	62
The Platinum Hall of Fame	62
Re: Phase II Study of Gemcitabine and Split-dose Cisplatin plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer	61
Everything But the Kitchen Sink: Comprehensive Nodal Irradiation with Androgen Deprivation in OLIGOPELVIS	61
P16 status is an independent predictor of overall survival in metastatic penile cancer in a large contemporary cohort	60

The Platinum Hall of Fame	60
More Accurate Imaging Is Not Stage Migration: Time To Move from “Hubble” to “Webb” in Hormone-sensitive Prostate Cancer	59
Severity of COVID-19 infection in prostate cancer patients and effect of ADT on disease presentation	58
Human Papillomavirus: One Less Worry for Men Too?	58
Prospective study of the relationship between clinical outcomes of enzalutamide and serum androgen levels measured by LC-MS/MS in CRPC patients	56
Geriatric nutritional risk index as a prognostic marker for patients with metastatic castration-resistant prostate cancer receiving docetaxel	56
Balancing efficacy and toxicity of docetaxel in patients with metastatic castration-resistant prostate cancer. Results from a pooled analysis of three prospective randomized trials	56
Fatigue, quality-of-life and metabolic changes in men treated with enzalutamide versus abiraterone plus prednisone for metastatic castration-resistant prostate cancer (HEAT): A randomised trial	56
Diabetes control in men with type 2 diabetes mellitus and prostate cancer treated with GnRH Agonists: A nationwide, population-based cohort study	55
Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0): An international multicenter study	55
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups	55
Randomized sham-controlled trial to evaluate the safety and effectiveness of radial waves for erectile dysfunction	53
Disease trajectories and outcomes for men with castration resistant prostate cancer by use of nation-wide population-based observational data	53
Comparative analysis of surgical outcomes and cost effectiveness of a novel 3-instrument technique for Robotic Assisted Radical Prostatectomy (RARP) with the standard 5-instrument technique	53
Results of percutaneous diathermocoagulation of spermatocele	53
Added value of radiological tumor stage in predicting early oncological outcomes in prostate cancer patients undergoing radical prostatectomy within clinical stage: A stage-by-stage analysis	52
Medications mostly associated with ejaculatory disorders: Assessment of the EudraVigilance (EV) and Food and Drug Administration (FDA) Pharmacovigilance databases entries	52
PET/CT allows for a reliable assessment of the real nodal burden in clinically node-positive prostate cancer patients candidate for radical prostatectomy: Results from a multi-institutional series	52
Is fast-MRI as accurate as multi-parametric MRI in the detection of clinically significant prostate cancer in biopsy naïve men? A prospective, single centre, non-inferiority randomized trial	52
Diagnostic value, oncological outcomes and safety profile of image-guided surgery technologies during robot-assisted lymph node dissection with sentinel node biopsy for prostate cancer	51
Beware excluding systematic biopsy in patients undergoing radical prostatectomy: A five year follow up study of biochemical recurrence free survival	51
Studying the interaction of germ cell tumors with the microenvironment reveals novel factors involved in cisplatin resistance	51
One day prostate cancer screening and diagnosis using Magnetic Resonance imaging and Digital Prostate Biopsy with fluorescence confocal microscopy	51
Safety of minimizing intensity of follow-up on active surveillance for clinical stage I testicular germ cell tumors	51
Application of Artificial Intelligence-based classifiers to predict the outcome measures and stone-free status following percutaneous nephrolithotomy for staghorn calculi: Cross-validation of data and	50
The learning curve of prostate MRI/TRUS target fusion biopsy after more than 1000 procedures: Residents’ experience	50
Prospective analysis of prostate cancer local staging with [18f] psma pet/mri combined with multiparametric mri – a comparison to histopathology in the radical prostatectomy specimen	49
Trans-ethnic genome-wide association study reveals new therapeutic targets for benign prostatic hyperplasia	49
Pre-existing detrusor overactivity leads to earlier artificial urinary sphincter failure and need for revision	49
Medium to long term health-related quality of life and treatment-related side-effects in patients treated with a single dose of adjuvant carboplatin for high-risk seminoma – results from a pilot study	48
Prostate Mapping: The Madrid protocol (Transperineal prostate biopsies combining Micro-ultrasound and mpMRI fusion biopsy) concordance with robotic radical prostatectomy specimens	47
Using a remote monitoring kit to predict re-admissions for patients discharged following radical cystectomy	46
Evaluation of the effect of umbilical cord derived urethral slings in bilateral pudendal nerves injury-induced urinary incontinence in female rats	46
Lessons learnt from 1010 consecutive robot assisted radical prostatectomies: Safe fellowship training	46
A new horizon-electromagnetic (EM) needle tip tracking to support mpMRI/US fusion transperineal prostate biopsies under local anaesthetia	46
Visioning - Evaluation of a solely MRI-based, PSA-free prostate cancer screening program	45
Are virtual clinics the new normal? A single-institution comparative analysis of outcomes and cost-effectiveness of virtual and face-to-face clinics	45
Comparing patient experience between telemedicine and traditional urology visits during the COVID-19 pandemic	45
Finding ideal timing of radiotherapy after radical prostatectomy – the impact on health-related quality of life	45
Comparison of relative survival and cause-specific survival in men with prostate cancer according to age and risk category. Nationwide, population-based study	44
Sacral Neuromodulation (SNM) in patients with neurogenic Lower Urinary Tract Dysfunction (nLUTD): A systematic literature review and meta-analysis covering over two decades	44
Symptoms suggestive of urinary tract infection rates among intermittent urinary catheter users: Real-world evidence research based on a longitudinal patient database in the UK	44
An algorithm to personalize nerve sparing in men with unilateral high-risk prostate cancer	43
Regional lymph node metastasis on PSMA-PET correlates with decreased BCR-free and therapy-free survival after radical prostatectomy	43
Evaluation of the bone-testis axis in patients with azoospermia undergoing surgical sperm retrieval	42
Delayed absent ejaculation in men presenting to the fertility clinic – retrospective cohort study	42
Couples presenting to Infertility Clinics - are they really infertile?	42
A new risk calculator to predict changes in IPSS score and risk of AUR / BPH-related surgery in BPH patients with moderate-severe symptoms at risk of disease progression receiving placebo, dutasteride	41
The Butterfly: A novel minimally invasive transurethral retraction device for BPH	40
Association between dietary inflammatory index and urinary flow rate: A nationwide study, nhanes 2009-2016	40
Biochemical recurrence risk adjusted follow-up after radical prostatectomy	40
Effect of SARS-CoV-2 infection upon male sexual function: A multi-center analytic study	39
The surgical learning curve for cancer control after robot-assisted radical prostatectomy	39
Prognostic variability among high-risk prostate cancer patients with pN1 disease according to the primary tumour pathologic features after radical prostatectomy	39
Hormone treatment–related adverse events (HTR AEs) with darolutamide (DARO) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) from the phase 3 ARAMIS study	38
Functional and sexual symptoms improvement after Rezum water vapor therapy for the treatment of LUTS/BPE: 3-year results from the first European observational study	38
Association of local progression with deterioration of urinary symptoms and occurrence of genitourinary adverse events (AEs) in nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC): Post hoc an	38
The tomato model: The cheapest and craziest way of learning how to puncture a kidney	38
10-year follow-up observation of idiopathic detrusor underactivity in the elderly living in community: Treatment and urodynamic changes	38
Combined surgical approach for treatment of refractory bladder neck contracture after TURP	37
PSMA-PET for recurrent prostate cancer and guidance of salvage treatments: Is the sooner always the better? (shoot blind or sharpshooting?)	37
Three-year outcomes after Aquablation compared to TURP: Efficacy and ejaculatory improvements sustained	37
Indocyanine green guidance during 3D augmented reality robot assisted partial nephrectomy: A step towards the “automatic” overlapping	37
A new technique of widening urethral plate in short bulbar strictures	36
New approach with fat grafting in the management of urethro-genital lichen sclerosus disease	36
Unfavourable outcomes after Holmium Laser Enucleation of the Prostate (HoLEP) are common also in the hands of a very esperienced surgeon – Results from a prospective trial (ExpHo)	36
Impact of early release of apical adenoma during Holmium Laser Enucleation of the Prostate (HoLEP) on early postoperative functional outcome	36
Validation of comprehensive pentafecta criteria after open radical cystectomy in bladder cancer patients with long-term oncological follow-up	35
ThuLEP vs. open simple prostatectomy for the treatment of prostates larger than 150 cc	35
Back to the future: Is the use of fasciocutaneous penile flap increasing in contemporary years for reconstructing the anterior urethra?	35
Final results of a prospective, randomized controlled trial assessing the impact of early Dorsal Venous Complex (eDVC) ligation on urinary continence recovery after robot-assisted radical prostatectom	34
Survival after neoadjuvant/induction combination immunotherapy versus combination platinum-based chemotherapy for stage III urothelial cancer	34
Androgen deprivation therapy and excess mortality during the COVID-19 pandemic	34
Robot-assisted laparoscopic radical cystectomy with intracorporeal ileal conduit diversion versus open radical cystectomy with ileal conduit in an ERAS setup (BORARC): A double-blinded, randomised fea	34
Adjuvant vs. progression-triggered treatment with gemcitabine after radical cystectomy in platinum-ineligible patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (AUO-AB 22-00): Long-te	34
Open vs. robot-assisted radical cystectomy with totally intracorporeal urinary diversion: 30-day and 90-day complication rates comparison from a single centre randomised controlled trial	34
Review of iatrogenic ureteric injuries management in a tertiary centre	33
KEYNOTE-365 cohort D: Pembrolizumab (pembro) plus abiraterone acetate (abi) and prednisone in chemotherapy (chemo)–naive patients with metastatic castration-resistant prostate cancer (mCRPC)	33
Is impotence a life-threatening condition?	33
Incontinence in boys and girls following succesful primary closure of bladder extrophy: Management with orthotopic ileal neobladder and costruction of anterior intrapelvic neourethra derived from detr	33

Beta-3 adrenoceptor agonist for the treatment of bladder dysfunction in children: A systematic review and meta-analysis	32
Secondary treatment for men with localized prostate cancer: A pooled analysis of PRIAS and ERSPC-Rotterdam datasets within the PIONEER data platform	32
68 Ga-PSMA PET/CT for preoperative lymph nosde staging of high risk prostate cancer	32
Retzius-sparing robot assisted radical prostatectomy has similar 1-year functional and oncological outcomes as standard robot-assisted radical prostatectomy: Results from a high volume UK centre	31
Autologous tunica albuginea cells in fibrin scaffold for correction of penile chordee: An experimental study in rabbits	31
Inguinal lymphadenectomy for penile cancer using a fascial sparing technique -outcomes from a single centre	31
Factors predicting the success of intradetrusor onabotulinum toxin-a treatment in children with neurogenic bladders due to myelomeningocele: The outcomes of a large cohort	31
A multi-surgeon learning curve analysis of overall and site-specific positive surgical margins after RARP	31
The lumbosacral cord repulsive environment does not halt sprouting of bladder afferents and NDO emergence in a NGF concentration-dependent process following spinal cord injury	30
Challenging cases in high-risk prostate cancer patients treated with Retzius-sparing robot-assisted radical prostatectomy	30
Effect of pelvic lymph node dissection and its extent on oncological outcomes in intermediate-risk prostate cancer patients: A multicenter study of the Turkish Urooncology Association	29
Duration of diabetes mellitus does not have influence on onset of bladder outlet obstruction	29
Transperineal interstitial laser ablation of the prostate as a minimally-invasive and effective therapeutic option for benign prostatic hyperplasia	29
Current impact of sexual and urinary symptoms in patients with multiple sclerosis and future perspectives: Results from a prospective, blinded, real-life study	29
Collaborative resilience program to enhance quality of life for post-penectomy patients: Dyadic coping perspective	29
Robot-assisted supratrigonal cystectomy and augmentation cystoplasty for neurological bladder in adults: Comparison of extracorporeal vs. intracorporeal diversion	29
Which patients with posterior urethral valves end with chronic renal disease? Follow up of 107 patients	29
Intravesical botulinum toxin use in detrusor overactivity: A comparison of long-term outcomes in patients with Multiple Sclerosis and Idiopathic Detrusor Overactivity	29
Prostatic artery embolization compared to trans-urethral resection of the prostate and prostatic urethral lift: A real-world population-based study	29
Transrectal ultrasound guided prostate needle biopsy is still a standard of care for prostate cancer diagnosis – A multicentre Australian analysis of infection rates	28
Our experience in the treatment of penile amputation injury	28
The comparasion of anxiety levels in children who underwent invasive or non-invasive urodynamic studies	28
Grade and stage misclassification in unfavorable intermediate vs high-risk NCCC prostate cancer candidates for RT plus short vs long-term androgen ADT	28
The man in the red coat – Samuel Pozzi (1846-1918): French pioneer of gynecology in the belle époque	28
MRI and MRI-targeted biopsy can detect cribriform cancer of the prostate	28
Risk factors of erectile dysfunction, painful erection and morphological complications after the penile fracture	28
A prospective comparative study of the accuracy and complications of transrectal and transperineal prostate biopsy in the MRI era	28
Safety and side effects after perineal prostate biopsy without antibiotic prophylaxis: Results of a multicenter trial with 30 days follow-up	28
Anxiety in men on active surveillance: A longitudinal comparison between Italian and Dutch PRIAS patients	28
Development of novel criteria to identify the optimal candidates for active surveillance among men with low-risk prostate cancer and a positive family history. Results from a large, single institution	28
Prognostic nomogram for predicting long-term survival in patients with retroperitoneal liposarcoma	28
First line avelumab in PD-L1+ve metastatic or locally advanced Urothelial Cancer (aUC) patients unfit for cisplatin: The ARIES trial	27
Adjustable artificial urinary sphincter (VICTO): Experience after 104 cases	27
Evaluation of the efficacies of methylphenidate and biofeedback treatments in giggle incontinence: One-year follow-up study	27
Key steps in the evaluation and treatment planning for successful Prostate Focal Cryotherapy	27
The recovery of renal functions following reversal of unilateral ureteric obstruction in hypertensive subjects	27
The effect of duration between sessions on biofeedback treatment in children with dysfunctional voiding	27
Inflammatory cytokines promote fibrosis in obstructed ureters	27
Impact of non-muscle invasive bladder cancer treatment history on the efficacy of pembrolizumab for patients with metastatic urothelial carcinoma	27
Development of a novel clinical and radiological risk score to predict septic complications in patients with obstructive uropathy	26
High concentration oxalate promotes intrarenal calcium oxalate crystals deposition via altering macrophage M1 polarization with change of the IRF-1/miR-301/CSF-1 signals	26
Lactobacillus vaginal suppositories for recurrent cystitis: A phase 2 clinical trial	26
Patients’ preferences, willingness-to-pay and cost of cystoscopy procedures: Results from a large survey-based study in the United Kingdom	26
Relapses of urogenital tract tuberculosis	26
Natural history of Atypical Small Acinar Proliferation (ASAP): A 10-year contemporary series	26
Bioluminescence imaging enables the study of bladder hyperreflexia during urinary tract infections in mice	26
Immunomodulatory roles of antimicrobial peptide LL-37 in urinary bladder bacterial infection	26
Combination of urinary-exosomal AMACR, ERG and PCA3 surpasses diagnostic power of serum PSA for patients with suspected prostate cancer	25
Is adjuvant amikacin to oral levofloxacine effective for prevention of febrile complications following transrectal prostate biopsy in patients with fluoroquinolone-resistant E.coli in the rectal flora	25
Real-world cost for first-line treatment for prostate cancer: A comparative cost analysis in the public sector	25
Effects of preoperative immunonutrition on surgical site infections for bladder cancer patients undergoing cystectomy and ileal conduit	25
Bacteraemia and bacteria spread into the irrigation fluid during percutaneous nephrolithotomy: A prospective study	25
Evaluation of the evolution of antibiotic prescription in the treatment of Healthcare-Associated Infections (HAIs) in a urology ward after implementing a treatment optimisation programme	24
Oncological outcomes for patients harboring positive surgical margins following radical cystectomy for muscle-invasive bladder cancer: A retrospective multicentric study of the EAU Young Academic Urol	24
Contemporary practice patterns in the treatment of Fournier’s gangrene – Implications for planning a Fournier’s gangrene registry	24
Active surveillance of small renal masses: Growth rate and oncological outcomes in a prospective series with standardized follow-up protocol	24
The use of abdominal drain after robot-assisted surgery in urology: Impact on postoperative pain	24
The results of treatment of patients with urolithiasis by Renotinex® in early postoperative period	23
The role of 3-D imaging reconstruction in real-life urologic practice: Results from a global survey	23
Relationship between the clinical profile of women with recurrent urinary tract infections and the prophylactic treatment chosen	23
Troubleshooting and cost-analysis of the senhance surgical robotic system in urology: A community hospital perspective	23
Hsa_circ_0005221 promotes prostate cancer progression through miR-339-5p/ STAT5a	23
Expression analysis of prostate cancer Hoechst 33342 side populations identifies the differing origins of CRPC	23
Comprehensive evaluation of MRI accuracy in local staging of penile cancer	22
Checkpoint-related proteins in liquid biopsies and their association with prognostic factors in penile cancer	22
Comparison of perioperative outcomes of single-port da Vinci SP and multiport da Vinci Xi robotic systems in robotic-assisted urologic surgeries	22
The introduction of novel robotic platforms and simulator tasks: Results of a multivariate analysis of factors impacting basic skills acquisition at the HugoTM RAS simulator	22
Do women choose urology residency as much as men? Female urology resident representation in Spain in the last decade	22
Health economics - implication of hypofractionated radiotherapy in prostate cancer	22
Development and validation of the metric-based assessment of a robotic dissection task on an avian model	22
Interest of FGSI and LRINEC prognostic scores in the management of Fournier gangrene	22
Urosepsis in malignant ureteral obstruction or obstructing stones: Is the treatment the same?	22
Genetic analysis identifies TNFRSF13B involved in prostate cancer progression	22
Urology residents simulation training improves clinical outcomes in laparoscopic partial nephrectomy	22
Peri- and postoperative outcomes of salvage robot-assisted radical prostatectomy in prostate cancer patients: A high-volume center experience	22
Gardnerella vaginalis: Is it an underestimated cause of urinary symptoms in males?	22
Real-world outcomes of Bladder Sparing Treatments (BSTs) in patients with high-risk non-muscle invasive bladder cancer, who failed or were intolerant to BCG therapy	21
The natural course and management strategies of renal angiomyolipoma: A comprehensive single-institution series with 20-year experience	21
Gross hematuria associated with anticoagulation and antiplatelet drugs – relevance of co-medication and pharmacological interactions	21
Phase I/II study of multipeptide cancer vaccine IMA901 in Japanese patients with advanced renal cell cancer with long-term follow up	21
Randomised Controlled trial comparing safety and efficacy of Urolift to Monopolar TURP	21
Surgical, functional and patients’ reported outcomes of adult acquired buried penis surgical management	21
Impact of the COVID-19 pandemic on urologic care delivery in the United States	21
Our initial experience with running a urological-oncology Multi-Disciplinary Team (MDT) clinic - A new model of care	21
Final validation of a Patient Reported Outcome Measure (PROM) for penile curvature surgery	19
Flap phalloplasty outcomes in female to male gender affirming surgery: A systematic review	19
What constitutes complexity rather than difficulty in the surgical reconstruction of pelvic fracture-related urethral injuries?	19
Surgical outcomes after treatment of urethral complications following metoidioplasty in transgender men	19
Practice variation in the management of adult hydroceles: A multinational survey	19
Surgical urinary continence outcomes in female exstrophy-epispadias patients	19
Does every suspicion of prostate cancer need imaging – a risk-based approach to reduce unnecessary mpMRI	19
Individual risk prediction of urinary incontinence after prostatectomy and impact on treatment choice in patients with localized prostate cancer	18
The effect of different post-prostatectomy incontinence definitions on outcomes reporting: a prospective review of a contemporary series of 1000 consecutive Robot-assisted Radical Prostatectomy	18
Robot assisted radical cystectomy with intracorporeal urinary diversion versus open radical cystectomy: Results from the iROC prospective randomised controlled trial	18
Is there bacterial growth inside the tunica vaginalis cavity in patients with unsalvageable testicular torsion?	18